Tiny study probes why islet transplants shield against low blood sugar
NCT ID NCT03079921
First seen May 12, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This early-phase study looked at how the nervous system helps control blood sugar in people with type 1 diabetes who received islet cell transplants. Nine participants received drugs that block certain nerve signals to see how their transplanted cells responded to low blood sugar. The goal was to understand why these transplants can protect against dangerous low blood sugar episodes, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania - Institute for Diabetes, Obesity and Metabolism
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.